Summary: The director of a laboratory has to be sure to give out reliable results for routine tests on automatic analysers regardless of the clinical context. However, he may find hyperbilirubinaemia in some circumstances, parenteral nutrition causing turbidity in others, and haemolysis occurring if sampling is difficult. For this reason, the Commission for Instrumentation of the Societe Frangaise de Biologie Clinique (SFBC) (president Alain Feuillu) decided to look into "visible" interferences -bilirubin, haemolysis and turbidity -and their effect on 20 major tests: 13 substrates/chemistries: albumin, calcium, cholesterol, creatinine, glucose, iron, magnesium, phosphorus, total bilirubin, total proteins, triacylglycerols, uric acid, urea, and 7 enzymatic activities: alkaline phosphatase, alanine aminotransferase, -amylase, aspartate aminotransferase, creatine kinase, -glutamyl transferase and lactate dehydrogenase measured on 15 automatic analysers representative of those found on the French market (Astra 8, AU 510, AU 5010, AU 5000, Chem 1, CX 7, Dax 72, Dimension, Ektachem, Hitachi 717, Hitachi 737, Hitachi 747, Monarch, Open 30, Paramax, Wako 30 R) and to see how much they affect the accuracy of results under routine conditions in the laboratory.
control. During the study we have particularly noted how poorly effective bichromatic procedures are; the choice of the secondary wavelength did not always prove useful, and thus the "corrections" were often not effective or only slightly so, or even had the contrary effect.
Introduction
In 1991, the committee for instrumentation of the Societe Fran?aise de Biologie Clinique (SFBC), president Alain Feuillu, decided to study the influence of "visible" Enzymes a-Amy l se: a-l,4-glucan 4-glucanhydrolase (EC 3.2.1.1) Alanine amino transferase: L-alanine : 2-oxoglutarate aminotransferase (EC 2.6.1.2) Alkaline phosphatase: orthophosphoric monoester phosphohydrolase (alkaline optimum) (EC 3.13.1) Aspartate amino transferase: L-aspartate : 2-oxoglutarate aminotransferase (EC 2.6.1.1) Creatine kinase: ATP : creatine N phosphotransferase (EC 2.7.3.2) γ-Glutamyl transferase: γ-glutamyl transpeptidase (EC 2.3.2.2) Lactate dehydrogenase: Δ-lactate : NAD+ oxidoreductase (EC 1.1. 1.27) interferences -bilirubin, haemolysis, turbidity -on the major routine tests carried out on automatic analysers. In many laboratories today, directors are often unaware of this type of problem. This led the committee to study how much these interferences affect the accuracy of results obtained for 20 routine analytes.
The results were presented at a workshop held in Eurolab (Nice -France) on the 29 April 1993.
Materials and Methods

Instruments and analytes
The instruments included in the study consisted of a sample representative of those found on the French market. The list was compiled with the aid of manufacturers and distributors as well as in collaboration with colleagues in the profession. We tried to have 2 sites for each instrument when possible. Table 1 lists the instruments evaluated with the corresponding sites.
Tab. 1 Instruments tested and evaluation sites. The following analytes were studied: 13 substrates/chemistries, albumin, calcium, cholesterol, creatinine, glucose, iron, magnesium, phosphorus, total bilirubin, total proteins, triacylglycerols, uric acid and urea; and 7 enzymatic activities: alkaline phosphatase, alanine aminotransferase, α-amylase, aspartate aminotransferase, creatine kinase, γ-glutamyl transferase and lactate dehydrogenase.
Of course, for closed systems, Astra, Chem 1, one part of the CX 7, Dimension, Ektachem, Paramax, the methods used are those provided by the manufacturers; for open systems, the methods used are described in table 2 for chemistries and table 3 for enzyme activities measurements.
Materials
Bilirubin was obtained from Fiuka (Mulhouse, France); conjugated bilirubin (sodium salt of ditauro-bilirubin) from Porphyrin Products (Paris, France); Intralipid™ (a 20% fat emulsion for intravenous injection) from Kabi Pharmacia (Paris, France).
/will easily show the apparent increases or decreases due to the various additions made (tab. 4). Also, we asked the evaluators to avoid using pools that already show haemolytic, icteric or lipaemic aspects. This implied preparing as many as 7 different pools.
Preparation of spiked solutions
Starting from freshly prepared stock solutions of bilirubin 5.1 mmol/1 in 0.025 mmol/1 NaOH, ditauro-bilirubin 5.1 mmol/1 in distilled water, plasma pools were prepared containing bilirubin concentrations between 0 and 500 μπιοΐ/ΐ, and ditauro-bilirubin concentrations between 0 and 250 μπιοΐ/ΐ. These pools were analysed immediately. Using a solution of haemolysed erythrocytes in distilled water, plasma pools were prepared containing haemoglobin concentrations between 0 and 240 μπιοΐ/ΐ; the concentration of haemoglobin was tested for all samples. Intralipid was added to plasma pools in order to obtain turbidity, tested by measuring the absorbance at 600 nm of a 1 : 20 dilution in 150 mmol/1 NaCl of the spiked plasma pools (turbidity index), equivalent to those of fresh sera with a concentration of triacylglycerols up to 7 mmol/1.
Plasma pools
Plasma pools were made up as carefully as possible to ensure the best results, i. e. trying to have concentrations of the analytes that 2.5 Protocol, procedure
The study was carried out using the SFBC protocol for the validation of techniques ("VALTEC") (1), in particular, appendix 9. The 1.5 to 2.5 1.5 to 2.5 1.5 to 2.5 1.5 to 2.5 1.5 to 2.5 1.5 to 2.5 1.5 to 2.5 evaluators were asked to pay special attention to the following points: running the tests in duplicate and adding the supplement material just prior to testing to avoid any transformation of the interfering substance.
Calculation of results
Final results were calculated by MacVALTEC 3.0 software (J. C. Eynard, D. Grafmeyer) running on an Apple Macintosh workstation on the basis of the measurements' average. If the results from 2 sites did not agree, i.e. if the difference between the two results was greater than or equal to twice the used acceptable limit (tab. 5), they were rechecked (of 83 values involved, 40 were corrected) by the two involved sites.
Results
Results by instrument
Firstly, we drew up "interferographs" as indicated in the VALTEC protocol with the concentration of interference on the x-axis (concentrations of bilirubin and haemoglobin, turbidity index), and the difference between the results of the pool and the spiked specimen expressed in % of the pool concentration on the y-axis.
As stated above, we split the tests into 2 groups, "chemistries" and "enzymes". Taking the 4 different interferences into consideration (bilirubin and ditauro-bilirubin, haemolysis and turbidity), we find we have 1 or 2 graphs per interference per group, i.e. 12 graphs per analyser which leads to more than 250 graphs in total. On each graph, we have indicated the "acceptable limits" as given by the VALTEC protocol (tab. 3). Note, however, that the protocol does not stipulate values for albumin or amylase.
Having drawn up the graphs, we then summarised the data in the form of 3 tables (tab. 6, 7, 8). Table 6 shows the results for total and ditauro-bilirubin; note the relationship between the 2 types of interference, the lack of interference for enzyme activities measurements, and above the very frequent interference shown for cholesTab. 5 Acceptable limits (according to SFBC-VALTEC guidelines) except for albumin and a-amylase. terol, creatinine, glucose, phosphorus, total proteins, triacylglycerols and uric acid determinations. Table 7 shows the results for haemolysis; note that haemolysis does interfere very frequently on chemistries determinations, particularly for iron, phosphorus, total proteins, bilirubin and uric acid as for the measurement of the activities of alkaline phosphatases and creatine kinase. Table 8 shows the results for turbidity. Note its less frequent interference; hardly ever on enzyme activities measurements, and only on some chemistries: e. g. glucose, iron, phosphorus, total proteins, bilirubin and uric acid.
Albumin
g/i μπιοΐ/l mmol/1 mmol/1 μττϊοΐ/l U/l U/l U/l U/l π/ι U/l U/l
Overall results per analyte
We also drew up "interferographs" per analyte with the results of several instruments for the same analyte, with the concentration of interference (concentrations of bilirubin and haemoglobin, turbidity index) of the x-axis, and the difference between the results of the pool and the spiked specimen expressed in concentration on the y-axis. Some representative examples of these graphs are shown ( fig. 1, 2,3 ).
In table 9, the results of the tests have been grouped together by analyte. The number of tests carried out (N) and the number of times an interference was seen at the highest level of addition are shown. This provides at least 2 types of information: the substance which interferes most often, and the analyte(s) which is (are) most sensitive to interference. In this way, 1443 tests were performed for which 324 interferences were noted, i. e. 22.5%. Haemolysis interferes the most often: in 348 tests, 120 were affected (34.5%). Total bilirubin interferes in 21.7% of cases (84 times out of 387 tests). Ditauro-bilirubin causes less interference, 16.7% (53 of 317 tests), but the concentrations were not as high, 250 μιηοΐ/ΐ as opposed to 500 μιηοΐ/ΐ for total bilirubin. For turbidity, interference was seen in 67 of 391 tests (17.1%).
The sensitivity to interference was not the same for all analytes; they can be divided up into 3 groups:
-slightly sensitive or not at all sensitive: in this group, less than 10% of specimens showed interference according to the norms of the protocol: urea, a-amylase, γ-glutamyl transferase, lactate dehydrogenase and alkaline phosphatase. -fairly sensitive: in this group, a significant interference was seen in 10 to 20% of cases noted as indicated in the protocol: albumin, calcium, magnesium, aspartate aminotransferase and creatine kinase. 
Discussion
What can be ascertained?
The interference can be placed into 3 categories: interference by addition, chemical interference and spectral interference.
Interferences by addition
In this case, visible interference occurs due to the addition of external substances which increase the apparent amount of analyte. Typically, haemoglobin falls into this category, being an indicator of red cell lysis (2, 3); the contents of the red cells will subsequently be found in the plasma, modifying its composition. Several of the analytes tested are affected in this way: red cells are rich in enzymes which will prevent correct readings if specimens are haemolysed (lactate dehydrogenase, transaminases). They are also rich in organic phosphate esters; thus the added amount can increase by up to 20%; in practice, this is not always found.
Haemoglobin is potentially a rich source of iron. However, the iron-porphyrin bonding is stronger than the bonding for the usual transport protein (transferrin), which means that releasing iron for tests can be adapted to avoid interference. This appears to be the case, as although 82% of tests were affected, this had nothing to do with an increase in iron ( fig. 4 ). Some tests were negatively influenced (2 cases, 2%). This suggests spectral interference.
Haemoglobin is also a protein which will also increase the plasma content in 68% of cases. Despite the fact that the added amount is small (maximum addition, 240 μιηοΐ/ΐ, approximately 3.8 g/1 for 70 g/1) this is still significant (protocol norm: 3 g/1 for 65 g/1, tab. 5). In certain cases, the interference was increased even more due to additional spectral interference.
The concentration of erythrocytic magnesium is around 3 times greater than plasmatic values. This, therefore, causes increases in 25% of the cases, which is nevertheless negligible as the concentration of haemolysis needs to be far greater than the concentration used in the study to have an eifect.
Creatinine kinase is strongly affected: in 43% of the cases the value increased, whereas with bilirubin and turbidity, virtually no difference can be seen. This is probably due to erythrocytic adenylate kinase which is not wholly inhibited under operating conditions (reagents contain adenosine monophosphate or diadenosine phosphate or a combination of the two).
Spectral interference
This is based on the law of added absorbances. All substances, other than the measured one, absorbing at the wavelengths used for the test will cause an apparent increase in the measured concentration. However, the substances included in the study have high absorbances 'at many different wavelengths ( fig. 5 ) and their spectra may change with the conditions ( fig. 6 and 7 ).
Turbidity will interfere more at shorter wavelengths (Rayleigh's law, fig. 5 ). Haemoglobin absorbs strongly at 415 nm ("Soret peak"), and less so between 530 and 600 nm, having 2 peaks at 540 and 570 nm ( fig. 5) (2, 3) . Therefore it may greatly interfere with measurements at these wavelengths (diazo-bilirubin, biuret total proteins). However, the structure of haemoglobin varies with the medium, precipitating in acid media, converting to haematin in alkaline media, becoming reduced, forming methaemoglobin or even carboxy or sulphohaemoglobin. These all have different spectra which will modify the extent of interference.
Bilirubin has a high absorbance between 400 and 520 nm (see fig. 5 ) and may interfere with the measurement of creatinine using the Jaffe method (tab. 12). Apparently, using a secondary wavelength does not correct this effect.
Chemical interference
The presence of foreign molecules in the solution may cause interference at different stages of the reaction, consuming some of the products.
The effect of haemoglobin on bilirubin measurement has been well-defined and is typical of this type of interference (tab. 13, in 68% of cases). In this case the spectral interference must also be taken into account as azobilirubin is measured at 540 nm corresponding to one of the wavelengths at which oxyhaemoglobin absorbs. However, if the pH changes duiing the reaction, the /of this, the reaction kinetics of the blank, if used, may differ from the sample so that the interference will be positive without a blank and negative with a blank.
Bilirubin may also interfere as a reducing substance: as it is easily oxidised to biliverdin and bilipurpurin, it will react with all oxidants present. Many enzymatic tests used for measuring substrates use oxidases producing hydrogen peroxide. In the presence of peroxidase, different chromogens can be oxidised. Bilirubin may reduce the concentration of the final product proportionally to its own concentration by consuming the hydrogen peroxide. Here we may find an augmented effect due to the spectral changes in the medium caused by the oxidation of bilirubin ( fig. 6 ). This explains why the results are systematically too low with the oxidase/peroxidase methods (tab. 14) for glucose, cholesterol, triacylglycerols and uric acid. This is also true for the enzymatic creatinine method on the Hitachi 717 (1) (tab. 6).
Lastly, bilirubin oxidises spontaneously in an alkaline medium, as in the Jaffe method for creatinine (tab. 1 2). ' ./·/ \ / This is probably the main reasons for the interferences found, rather than any spectral effects.
Italic numbers = significant interference (according to the norms) at the highest level of interference haemoglobin may be transformed to haematin or methaemoglobin. At the same time, the bilirubin being measured is destroyed by haemoglobin peroxidase. On top
How do the instruments deal with this problem?
Basically, it is impossible to eliminate some kind of interferences -e. g. those caused by cell lysis. It is nevertheless possible to influence spectral and chemical interferences.
Tab. 14 Oxidase/peroxidase methods -The influence of bilirubin. 
Physical removal of impurities
This study confirms the previous one published by Glick in 1986 (5, 6) which showed that instruments using specimen pretreatment (strips with a layer for separation, dialysis) were best at eliminating both spectral and chemical interferences. In the same way, the SFBC method for iron chemically eliminates interference using trichloroacetic acid prior to carrying out the assay. The Kodak multilayer slides have a similar effect though, to a lesser extent, through the use of hydrophilic polymers on which the sample is deposited and which allow the passage of a set volume of aqueous liquid via capillaries. This blocks macromolecules and other substances which could interfere with measurement.
Operational conditions -Blank measurement
"Visible" interferences, particularly turbidity (4), may be minimised or even corrected by adjusting the reaction medium using e. g. a sample blank.
a) blank measurement:
This involves measuring the sample absorbance, once suitably diluted, prior to adding the reagent. The absorbance measured (Al) is subtracted from the final absorbance (A2). There are several ways to realize this blank. The first method uses two different reagents (blank and reagent mixture) and two cuvettes. The second method is performed by sequentially adding the reagents which, however, is not always possible: some automated systems work only with a single reagent, or only have one position to dispense the reagents. Furthermore, these methods need two consecutive measurements on the same sample. Finally, a single reagent may be used with an early reading which is ranked as a blank, or with multiple readings to estimate the blank value. This, however, requires successive measurements on the same sample: if certain automated systems having several photometers have a limited number of measurements at fixed intervals, others systems only have one photometer. In that case, we will distinguish between the few automated systems which can only measure at the end point, and the many automated systems which, fortunately, can make several measurements. Here, the photometer may well be fixed, but the cuvettes will be transported in front of the photometer for readings at set intervals. If it is mobile, it will be able to read absorbances on all the cuvettes at the required times. These settings mean that many readings can be made for each sample and thus a blank value can be easily obtained.
This shows how important the concept of an instrument is, as well as the available algorithms, at different levels (treatment of the reaction medium, treatment of the readings, treatment of other data, e. g. the number of reagents per test, the number of readings per cuvette b) blank preparation: this also makes a difference (tab. 15). Better results are often obtained if 2 cuvettes with a blank are used rather than sequentially adding the reag ents. When the blank develops slowly, automated systems are often not able to wait for its absorbance to stabilise before adding the reagent. Under these conditions, two cuvettes may be used, one containing all the reagents and the other containing all of them except one necessary for the reaction to take place. The blank is the one in which, after the reaction time, no colour is visible. The interference will be the same in both cuvettes.
In the study, several examples show that the use of 2 cuvettes produces excellent results. For example, on the 2AU 510, one used sequential blanking, the other 2 cuvettes. The results ( fig. 8) shown in the results for bilirubin in the presence of haemolysis using 2 cuvettes: in this case, the chemical interference is difficult to remove (e. g. bilirubin on the Open 30 and the AU 510). The use of 2 cuvettes suffers one drawback reducing the throughput of tests by half, although generally improving the results overall.
Measuring conditions
Clinical chemistry analysers try, on the whole, to deal with spectral interference by acting on the readings made: a) choice of read wavelength: the number of wavelengths available on automated systems is usually limited. They mostly use interference filters: some use light receptive arrays, but the number of diode receptors used is relative small (generally from 10 to 16). Thus, the wavelength used is not always the best. For example, the interference of bilirubin and haemolysis on uric acid measurement using the oxidase/peroxidase methods (tab. 16) varies with the wavelength. b) Multiwavelength analysis appears attractive: since the interference may vary with time, corrections can be carried out at the end of the reaction by reading at different wavelengths and applying algorithms for correction. The easiest -and almost the only -method used in our experience in 1992, is bichromatic measurement. This involves using a secondary (side) wavelength to measure the interfering substance. The substance to be measured does not absorb at this wavelength. This measurement is then subtracted from that of the analyte required at its wavelength. This assumes that the absorbance of the interfering substance is the same at both wavelengths, which is rarely the case. Obviously, the bichromatic principle will not help unless the interfering substance does not absorb at the secondary wavelength. For this reason, the corrections will either be partial or overestimated.
What can be obtained from the results?
By taking some relatively complex examples, we shall see that mastering "visible" interferences is very difficult if not impossible. Table 17 shows the results obtained: the instruments are listed by method, for the most part "uricase/catalase/dehydrogenase" and "uricase/peroxidase" with rarely "uricase 293 nm" and "uricase by reflectance photometry".
The uric acid case
Clearly, the "uricase/catalase/dehydrogenase" methods come out better than the "uricase peroxidase" methods which are often subject to interference (bilirubin and haemolysis in particular). Wherever possible on open systems, both manufacturers and end users should use the "uricase/catalase/dehydrogenase" methods. The influence of turbidity on the Chem 1 is surprising: the instrument uses sequential additions and there is probably a clarification of the reaction medium after the first reading.
For the "uricase/peroxidase" methods which very often use the Trinder's chromogen (4-aminophenazone and phenol or phenol derivatives), the choice of the secondary wavelength does not always appear to be the most appropriate. The same can be said for the other tests using these methods (glucose, cholesterol, triacylglycerols). Here we find virtually any wavelength (tab. 18). It seems that the best wavelength would be 560 nm, where haemoglobin and bilirubin absorbance is minimal, but the choice depends on the substrate used in the indicator reaction. It is also interesting to note that the sensitivity varies according to chromogen used -phenol bonded with halogens to varying degrees, /?-chlorophenol, dichlorhydroxybenzene-sulphonic acid -which itself depends on the concentration of the substrate (glucose and cholesterol 5, triacylglycerols 2, uric acid 0.5). This leads to paradoxical results when considering that interferences -e. g. cholesterol and glucose -are more sensitive to bilirubin.
As for haemolysis, the uric acid test, using this method, suffers greater interference than other tests using the methods (cholesterol, glucose, triacylglycerols), which are diluted 1 : 100, whereas to improve sensitivity, uric acid is only diluted 1 : 50.
Finally, a sample blank only improves results where lipids are in excess. (1) uses a blank and has a negative interference; system (2) has none and has a positive interference. The choice of primary wavelength is also important: haemoglobin has 2 peaks at 540 and 575 nm, and 2 minimum absorbance at 509 and 559 nm ( fig. 5 ). This interference is also seen on the Ektachem.
The case of iron measurement
Iron, in the present study, is very sensitive to interference (tab. 20): results are affected in 23.4% of cases overall (haemolysis: 64.6% -turbidity: 23.5%).
The interference caused by haemolysis is quite interesting since one micromole of haemoglobin (monomer) contains one micromole of iron. Thus, the final point of addition at 240 μπιοΐ/ΐ of haemoglobin represents a large increase in iron in the specimen which would appear to make this test of no interest. However, for reasons we are unable to understand, there is no interference observed with certain reagents. In fact, this depends especially on the pH of the reaction medium and the detergents used in the reagents: if the iron is not released but interference still exists, this is probably optical, and should not be seen if a sample blank is used; if the iron is released, it would be "normal" to see an interference of 1200%. Fig. 8 The interest of 2-cuvette blanking -e.g. interference of turbidity on iron measurements on 2 AU 510 analysers using the same method and the same reagents; the first one AU 510 (1) works with a two cuvette blank, the second one AU 510 (2) with a sequential addition of reagents. in the operating conditions: results greatly vary when a single reagent is used; on the Hitachi 717, which uses 405 nm as secondary wavelength, all the interferences have an effect, whereas on the Paramax, which uses the same secondary wavelength, there is hardly no effect! The reagent composition (concentrations, surfactants and additives) certainly has something to do with this.
We were surprised to find that in 10 out of the 19 cases (52.6%) where bilirubin and ditauro-bilirubin were tested, ditauro-bilirubin interfered more than bilirubin (positive interference). Since the reaction takes place under extremely acidic conditions (pH < 1), not only does the accuracy suffer (hydrolysis of organic phosphoric esters), but, at this pH, the absorption spectra of the 2 bilirubin is altered as well ( fig. 7) .
"On the whole, it seems better to work under the following conditions: use a 2-reagent system with a sample blank either using 2 cuvettes or with sequential addition; avoid using a secondary wavelength, or one as neutral as possible (> 600 nm).
Conclusions
This study shows that results obtained from automated systems may not always be accurate in the presence of substances like haemoglobin or bilirubin or even when the specimen is cloudy in sufficiently high concentrations in the sample. We found that results were affected in 22.5% of cases under these conditions. The risk of interference is increased by the use of primary tubes often covered by several labels preventing visual inspections of the serum or plasma.
These results confirm those of Click (5, 6) published in the United States in 1986 on the automated systems on the market at that time. It confirms the different publications and sessions at congresses, found in the literature, which have discussed interference problems. They indicate the same evolution that is seen in national and regional control schemes for quality control (External QC), whereby automation has improved precision considerably, but not accuracy as can be seen in the disper-,έίοη of the results obtained for the same test in all the laboratories.
The instrument manufacturers do employ corrective devices for interferences (blanking, bichromatic analysis). Most of these systems suffer imperfections making these corrections illusory. Available solutions however work. A few automated systems use physical methods (diffusion through a support material) to eliminate interfering substances, which is satisfactory for both chemical and spectral effects. On the other hand, progress in spectrophotometric measurement should yield good results even in the presence of coloured parasitic substances through the use of diode arrays (which can read spectra in a very short time) and computer software to treat the data obtained. These could easily be incorporated into the instruments (some already provide such equipment but do not use all the wavelengths).
Results obtained for clinical chemistry analysers can be improved in several ways: improve the preanalytic phase, use sample blanks, get optical measurements (bi or polychromatic procedures) under control. The precision on the automated systems is good and well mastered, much more so than the accuracy. This study illustrates the problems involved in accuracy and correction of interferences, as the results are very heterogeneous. There is only one way to treat chemical interferences. Eliminate the interfering substance: e. g. bilirubin with bilirubin oxidase, vitamin C with ascorbic oxidase.
Manufacturers try to satisfy their customers' needs, so users of automated systems have an important role to play. As soon as laboratory directors are convinced that they need accurate results, which indeed can and should improve, manufacturers will try to improve the automated systems. The choice of an automated system for the laboratory is always a big investment and will affect the quality of results. It should be as rigorous as possible in terms of quality. 
